13F-HR filed by Camber Capital Management LP
Camber Capital Management LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 25 holding rows worth $1,065,228,750.
- Accession
- 0001654954-25-009644
- Filer
- CIK 1444043
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 25 entries on the cover page, a total value of $1,065,228,750 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,065,228,750 with VALUE read as dollars as filed, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 500,000 | $308,925,000 | dollars as filed | put |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 1,000,000 | $91,210,000 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 2,850,000 | $86,298,000 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 300,000 | $73,344,000 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 1,050,000 | $72,429,000 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 800,000 | $47,216,000 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 300,000 | $43,635,000 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 250,000 | $43,150,000 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 500,000 | $39,580,000 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 1,000,000 | $38,400,000 | dollars as filed | call |
| Pfizer Inc. | 717081103 | COM | 1,500,000 | $36,360,000 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 600,000 | $32,982,000 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 100,000 | $31,197,000 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 2,750,000 | $24,557,500 | dollars as filed | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 2,150,000 | $14,964,000 | dollars as filed | |
| ZIMVIE INC | 98888T107 | COM | 1,600,000 | $14,960,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 850,000 | $14,713,500 | dollars as filed | |
| MYRIAD GENETICS INC | 62855J104 | COM | 2,000,000 | $10,620,000 | dollars as filed | |
| EVOLENT HEALTH INC CL A | 30050B101 | Stock | 850,000 | $9,571,000 | dollars as filed | |
| CONCENTRA GROUP HOLDINGS PAR | 20603L102 | COMMON STOCK | 400,000 | $8,228,000 | dollars as filed | |
| INOGEN INC | 45780L104 | COM | 975,000 | $6,854,250 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 400,000 | $5,596,000 | dollars as filed | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 450,000 | $4,963,500 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 125,000 | $2,775,000 | dollars as filed | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 900,000 | $2,700,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001654954-25-009644 | this filing | 2025-08-14 | acceptance time not in the bulk data set |